New P1/2 trial • IO biomarker • Metastases
|
EGFR (Epidermal growth factor receptor) • ALK (Anaplastic lymphoma kinase) • ROS1 (Proto-Oncogene Tyrosine-Protein Kinase ROS) • HAVCR2 (Hepatitis A Virus Cellular Receptor 2)
|
PD-L1 expression • ALK fusion • ALK mutation • ROS1 fusion • ROS1 mutation
|
benmelstobart (APL-502) • TQB2618